A vaccine to personalize colorectal cancer treatment

0 Views

07/13/23

MD Anderson researchers and physicians are working together to treat colorectal cancer patients using a new personalized cancer vaccine available through a clinical trial. By identifying 10 targets specific for each patient's cancer, Gregory Lizee, Ph.D., and his team are designing personalized vaccines that direct the immune system toward patients' tumors.

The goal of this immunotherapy treatment is to generate a more powerful anti-tumor response without damaging normal tissue. In this video, Lizee explains how the specific targets for each colorectal cancer patient are identified, why personalizing treatment is important, and how this approach can potentially be used to treat other cancer types.

Request an appointment at MD Anderson by calling 1-877-632-6789 or by completing our online self-referral form: https://my.mdanderson.org/Requ....estAppointment?cmpid